FedBizOpps banner

Login to begin searching the FBO/CBD
Home Page
CBD/FBO Online
About Us
Contact Us
No. Notes

Popular Searches

Popular Categories

Development of Personalized Bacteriophage Therapeutic for the treatment of Complicated and Multidrug Resistant Bacterial Infections

General Information

Document Type:PRESOL
Posted Date:Dec 20, 2018
Category: Research and Development
Set Aside:N/A

Contracting Office Address

Attn: MCMR-AAA 820 Chandler Street Frederick, MD 21702-5014 MD 21702-5014


This is a pre-announcement only. No response is required at this time. The Medical Technology Enterprise Consortium (MTEC) is excited to post this pre-announcement for a Request for Project Proposals (RPP) focused on the development of a bacteriophage prototype for the treatment of multidrug resistant (MDR) bacterial infections employing a tailored, precision approach. The overall end goal of the program is a commercial bacteriophage product that is approved by the U.S. Food and Drug Administration (FDA) and suitable for use by the U.S. Military. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (20-DEC-2018); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.

Original Point of Contact

POC Rebecca Harmon, Phone 843-760-3358

Place of Performance

Link: Link To Document
Bookmark This Notice
Print View